Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Seelos Therapeutics Inc (SEEL)

Seelos Therapeutics Inc (SEEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,776
  • Shares Outstanding, K 106,091
  • Annual Sales, $ 0 K
  • Annual Income, $ -66,050 K
  • 60-Month Beta 2.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.84
Trade SEEL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.52
  • Most Recent Earnings -0.20 on 08/05/22
  • Next Earnings Date 08/08/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 182.12% ( +82.51%)
  • Historical Volatility 91.17%
  • IV Percentile 83%
  • IV Rank 35.49%
  • IV High 499.60% on 06/07/22
  • IV Low 7.47% on 06/14/22
  • Put/Call Vol Ratio 1.08
  • Today's Volume 333
  • Volume Avg (30-Day) 475
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 77,953
  • Open Int (30-Day) 75,740

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.32
  • Number of Estimates 1
  • High Estimate -0.32
  • Low Estimate -0.32
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -190.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8316 +14.23%
on 07/27/22
1.0400 -8.66%
on 08/08/22
-0.0125 (-1.30%)
since 07/12/22
3-Month
0.5230 +81.63%
on 05/13/22
1.0400 -8.66%
on 08/08/22
+0.4378 (+85.49%)
since 05/12/22
52-Week
0.4803 +97.77%
on 05/12/22
2.7900 -65.95%
on 09/29/21
-1.2101 (-56.02%)
since 08/12/21

Most Recent Stories

More News
Seelos Therapeutics Doses First Patient in an Open Label Basket Study of SLS-005 in Amyotrophic Lateral Sclerosis in Australia and Provides an Enrollment Update of its Study on the HEALEY ALS Platform

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central...

SEEL : 0.9499 (+4.79%)
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating...

CYBN.NE : 1.020 (-6.42%)
MMED.NE : 0.930 (+16.25%)
TSLA : 900.09 (+4.68%)
CYBN : 0.8000 (-6.61%)
MNMD : 0.7256 (+11.58%)
CMPS : 18.35 (+5.91%)
SEEL : 0.9499 (+4.79%)
NUMI.TO : 0.3200 (+14.29%)
NUMIF : 0.2495 (+11.53%)
World's Richest Man Says Psychedelics Could Make a Real Difference in Mental Health

/PRNewswire/ -- Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a number of mental health conditions....

CMPS : 18.35 (+5.91%)
NUMI.TO : 0.3200 (+14.29%)
CYBN : 0.8000 (-6.61%)
MNMD : 0.7256 (+11.58%)
SEEL : 0.9499 (+4.79%)
NUMIF : 0.2495 (+11.53%)
Oregon to Become the First State to Legally Roll Out Psilocybin

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found...

CYBN.NE : 1.020 (-6.42%)
MMED.NE : 0.930 (+16.25%)
CYBN : 0.8000 (-6.61%)
MNMD : 0.7256 (+11.58%)
CMPS : 18.35 (+5.91%)
JNJ : 165.30 (-1.10%)
SEEL : 0.9499 (+4.79%)
Why Psychedelics Could Soon Replace Antidepressants

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...

CYBN.NE : 1.020 (-6.42%)
MMED.NE : 0.930 (+16.25%)
MYCO.NE : 0.770 (unch)
SEEL : 0.9499 (+4.79%)
MNMD : 0.7256 (+11.58%)
CMPS : 18.35 (+5.91%)
MYCOF : 0.5800 (-15.94%)
CYBN : 0.8000 (-6.61%)
Demand for Toad Venom Rises Along With the Booming Psychedelics Market

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – March 30, 2022 –  Depression and anxiety affect millions around the world and the venom of a toad is the latest  psychedelic...

MMED.NE : 0.930 (+16.25%)
MYCO.NE : 0.770 (unch)
NUMI.TO : 0.3200 (+14.29%)
NUMIF : 0.2495 (+11.53%)
SEEL : 0.9499 (+4.79%)
MNMD : 0.7256 (+11.58%)
MYCOF : 0.5800 (-15.94%)
CMPS : 18.35 (+5.91%)
Therapy Shake-Up Called for by Mental Health Experts Seeking Solutions for Mental Health Crisis

VANCOUVER – USA News Group – According to a new report by a team of 25 experts from 11 different countries estimates that approximately 5% of the world’s adult population is living with depression....

MOOD.CN : 0.045 (unch)
FTRP : 0.8500 (unch)
FTRP.TO : 1.11 (+0.91%)
NUMI.TO : 0.3200 (+14.29%)
NUMIF : 0.2495 (+11.53%)
SEEL : 0.9499 (+4.79%)
ABBV : 142.60 (+0.37%)
Mental Health 2022: Ketamine Could be a Game-Changer in the Treatment of Anxiety

Psychedelics could be a game-changer in the treatment of mental health. So far, studies show how useful they can be in treating mental health issues, such as obsessive compulsive disorder, PTSD, opioid...

ATAI : 4.58 (+3.39%)
SEEL : 0.9499 (+4.79%)
FTRP : 0.8500 (unch)
NUMI.TO : 0.3200 (+14.29%)
NUMIF : 0.2495 (+11.53%)
NEON.CN : 0.095 (-5.00%)
NMDBF : 0.0685 (+20.18%)
Psychedelics Offer Hope for Mental Disorders, Addiction

NetworkNewsWire Editorial Coverage : Global destigmatization, changing regulations and an upswing in research are speaking loudly to the opportunity for psychedelics to provide tangible improvements in...

MYCOF : 0.5800 (-15.94%)
MNMD : 0.7256 (+11.58%)
SEEL : 0.9499 (+4.79%)
PSIL : 3.28 (+2.82%)
PSYK : 21.36 (+1.61%)
Seelos Therapeutics Presents a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central...

SEEL : 0.9499 (+4.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Seelos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the development and advancement of novel therapeutics to address unmet medical needs for central nervous system disorders. The company's product pipeline consists of SLS-002, SLS-006, SLS-008, SLS-010 and SLS-012 which...

See More

Key Turning Points

3rd Resistance Point 1.0658
2nd Resistance Point 1.0166
1st Resistance Point 0.9833
Last Price 0.9499
1st Support Level 0.9008
2nd Support Level 0.8516
3rd Support Level 0.8183

See More

52-Week High 2.7900
Fibonacci 61.8% 1.9077
Fibonacci 50% 1.6351
Fibonacci 38.2% 1.3626
Last Price 0.9499
52-Week Low 0.4803

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar